US 11,832,617 B2
Anti-viral paints and coatings and articles comprising same
Claude Steven McDaniel, Austin, TX (US)
Assigned to Reactive Surfaces Ltd., LLP, Austin, TX (US)
Filed by REACTIVE SURFACES LTD., LLP, Austin, TX (US)
Filed on Dec. 19, 2022, as Appl. No. 18/068,509.
Application 17/378,537 is a division of application No. 17/037,415, filed on Sep. 29, 2020, granted, now 11,102,983, issued on Aug. 31, 2021.
Application 18/068,509 is a continuation of application No. 17/378,537, filed on Jul. 16, 2021, abandoned.
Application 17/037,415 is a continuation in part of application No. 16/266,096, filed on Feb. 3, 2019, abandoned.
Claims priority of provisional application 63/036,480, filed on Jun. 9, 2020.
Prior Publication US 2023/0270118 A1, Aug. 31, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A01N 63/40 (2020.01); A01N 63/50 (2020.01); A01N 25/10 (2006.01)
CPC A01N 63/40 (2020.01) [A01N 25/10 (2013.01); A01N 63/50 (2020.01)] 20 Claims
 
1. A product effective in mitigating contamination of a surface thereof by particles of an infectious virus to humans for which an enveloped bacterial virus characterized by having a lipid-rich viral membrane envelope is a biological surrogate, wherein the product is made by a process comprising the steps of:
applying an anti-viral functionalized coating composition on a surface of a substrate to create an anti-viral functionalized surface thereof, wherein the anti-viral functionalized coating composition comprises an effective amount of an anti-viral additive and a specified amount of a polymeric coating composition, wherein the anti-viral additive comprises antimicrobial peptide and lipolytic enzyme, wherein said antimicrobial peptide comprises SEQ ID NO. 40, wherein the effective amount of the anti-viral additive and the specified amount of the polymeric coating composition enable the anti-viral functionalized surface to provide the product with an effective amount of contamination mitigation of particles of the biological surrogate contacting the anti-viral functionalized surface, and wherein the anti-contaminant additive comprising said SEQ ID NO. 40 and said lipolytic enzyme provides increased neutralization of activity of the biological surrogate as compared to said neutralization when the anti-contaminant additive comprises only said SEQ ID NO. 40 or said lipolytic enzyme.